New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - dl-alpha tocopherol 0.91 mg/ml;  ; ergocalciferol 0.5 µg/ml; phytomenadione 15 µg/ml; retinol palmitate 194.1 µg/ml (corresponding to 99 ug retinol) - emulsion for injection - active: dl-alpha tocopherol 0.91 mg/ml   ergocalciferol 0.5 µg/ml phytomenadione 15 µg/ml retinol palmitate 194.1 µg/ml (corresponding to 99 ug retinol) excipient: egg lecithin glycerol sodium hydroxide soya oil water for injection - vitalipid n adult is indicated as a supplement in complete intravenous nutrition to meet the daily requirements of the fat-soluble vitamins a, d2, e and k1.

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - dl-alpha tocopherol 0.64 mg/ml;  ; ergocalciferol 1 µg/ml; phytomenadione 20 µg/ml; retinol palmitate 135.3 µg/ml (corresponding to 69 ug retinol) - emulsion for injection - active: dl-alpha tocopherol 0.64 mg/ml   ergocalciferol 1 µg/ml phytomenadione 20 µg/ml retinol palmitate 135.3 µg/ml (corresponding to 69 ug retinol) excipient: egg lecithin glycerol sodium hydroxide soya oil water for injection - vitalipid n infant is indicated in paediatric patients up to 11 years of age as a supplement in complete intravenous nutrition to meet the daily requirements of the fat-soluble vitamins a, d2, e and k1.

Israel - English - Ministry of Health

cure medical & technical supply - ergocalciferol; phytomenadione; retinol palmitate; tocopherol - concentrate for solution for infusion - phytomenadione 15 mcg/ml; ergocalciferol 0.5 mcg/ml; tocopherol 0.91 mg/ml; retinol palmitate 194.1 mcg/ml - combinations - combinations - vitalipid n adult is indicated in adult and children above 11 years of age as a supplement in iv nutrition to meet the daily requirement of the fat soluble vitamins a, d2, e,k1.

Malta - English - Medicines Authority

aldox limited school street tarxien, malta - folic acid, ascorbic acid, biotin, calcium, colecalciferol, copper, cyanocobalamin, dl, alfa, tocopherol, panax ginseng, extract, nicotinamide, thiamine mononitrate, zinc, iron, magnesium, manganese, selenium, lecithin, pyridoxine hydrochloride, retinol, riboflavin - soft capsule - folic acid 100 µg ascorbic acid 60 mg biotin 150 µg calcium 100 mg colecalciferol 200 iu copper 2 mg cyanocobalamin 1 µg dl-alfa-tocopherol 10 mg panax ginseng extract 40 mg nicotinamide 18 mg thiamine mononitrate 1.4 mg zinc 1 mg iron 10 mg magnesium 10 mg manganese 2.5 mg selenium 50 µg lecithin 100 mg pyridoxine hydrochloride 2 mg retinol 800 mg riboflavin 1.6 mg - vitamins

Philippines - English - FDA (Food And Drug Administration)

tgp pharma, inc. - multivitamins , minerals - capsule - retinol acetate (vit.a)-5,000 iu, cholecalciferol (vit.d3)-500 iu, thiamine hydrochloride (vit.b1)-15mg, riboflavin (vit.b2)-10m

Philippines - English - FDA (Food And Drug Administration)

pharma-surrey international, inc.; distributor: 46 bulusan st., sta. mesa heights, quezon city, metro manila - multivitamins - solution for intravenous infusion - retinol concentrate (vitamin a) cholecalciferol (vitamin d) alpha tocopheryl acetate (vitamin e) ascorbic acid (vitamin c) nicot

Philippines - English - FDA (Food And Drug Administration)

aybc trading - multivitamins - syrup (oral drops) - retinol palmitate (vit. a) 1083 iu/ thiamine hydrochloride (vit. b1) 400 mcg/ riboflavin (vit. b2) 400 mcg/ niacinamide (vit. b3

Philippines - English - FDA (Food And Drug Administration)

peniel pharmaceuticals - multivitamins - syrup - retinol acetate (vit.a)-5,000 iu, cholecalciferol (vit.d3)-500 iu, thiamine hydrochloride (vit.b1)-15mg, riboflavin (vit.b2)-10m

Australia - English - Department of Health (Therapeutic Goods Administration)

fit-bioceuticals pty ltd - retinol acetate, quantity: 172 microgram (equivalent: vitamin a, qty 150.05 re); rumex crispus, quantity: 300 mg (equivalent: rumex crispus, qty 1.5 g); phytolacca americana, quantity: 33.3 microgram (equivalent: phytolacca americana, qty 333 microgram); zinc amino acid chelate, quantity: 16.5 mg (equivalent: zinc, qty 3.3 mg); galium aparine, quantity: 400 mg (equivalent: galium aparine, qty 2 g); echinacea purpurea, quantity: 83.34 mg (equivalent: echinacea purpurea, qty 1 g; equivalent: cichoric acid, qty 2.08 mg; equivalent: echinacoside, qty 41.6 microgram); arctium lappa, quantity: 200 mg (equivalent: arctium lappa, qty 1 g) - tablet, film coated - excipient ingredients: acacia; crospovidone; dl-alpha-tocopherol; carnauba wax; macrogol 400; hypromellose; maize starch; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; magnesium stearate; croscarmellose sodium; maltodextrin; colloidal anhydrous silica; povidone - antioxidant/reduce free radicals formed in the body ; traditionally used in western herbal medicine to alterative/blood cleanser/depurative/purifier ; aid/assist/helps connective tissue production/formation ; traditionally used in western herbal medicine to maintain/support healthy lymphatic system ; traditionally used in western herbal medicine to decrease/reduce/relieve symptoms of mild eczema/dermatitis ; traditionally used in western herbal medicine to decrease/reduce/relieve symptoms of mild psoriasis ; maintain/support skin health ; maintain/support skin integrity/structure ; maintain/support wound healing ; traditionally used in western herbal medicine to aid/assist flushing of the urinary tract

United States - English - NLM (National Library of Medicine)

hospira, inc. - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), retinol (unii: g2sh0xkk91) (retinol - unii:g2sh0xkk91), ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), de - ascorbic acid 80 mg in 5 ml - m.v.i. pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. m.v.i. pediatric is contraindicated in patients who have: - a history of known hypersensitivity to any of the vitamins or excipients in m.v.i. pediatric [see warnings and precautions (5.2), adverse reactions (6)] - an existing hypervitaminosis the safety and effectiveness of m.v.i. pediatric for the prevention of vitamin deficiency have been established in pediatric patients up to 11 years of age receiving parenteral nutrition. the safety and effectiveness of m.v.i. pediatric have not been established in pediatric patients older than 11 years of age. m.v.i. pediatric contains aluminum that may be toxic for premature neonates. aluminum levels should be monitored periodically during administration of m.v.i. pediatric to p